Cavernous neurotomy in the rat is associated with the onset of an overt condition of hypogonadism

Journal of Sexual Medicine

Volumn 6, Issue 5, 2009, Pages 1270-1283

  Vignozzi, Linda ^a   Filippi, Sandra ^a   Morelli, Annamaria ^a   Marini, Mirca ^a   Chavalmane, Aravinda ^a   Fibbi, Benedetta ^a   Silvestrini, Enrico ^a   Mancina, Rosa ^a   Carini, Marco ^a   Vannelli, G Barbara ^a   Forti, Gianni ^a   Maggi, Mario ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Bilateral cavernous neurotomy; Erectile dysfunction; Hypogonadism; Tadalafil; Testosterone

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; LUTEINIZING HORMONE; MESSENGER RNA; NEURONAL NITRIC OXIDE SYNTHASE; PHOSPHODIESTERASE V; TADALAFIL; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; ENDOTHELIAL DYSFUNCTION; ERECTILE DYSFUNCTION; HYPOGONADISM; HYPOXEMIA; LEYDIG CELL; LONG TERM CARE; MALE; NERVE SURGERY; NONHUMAN; PATHOGENESIS; PENILE BLOOD FLOW; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADICAL RETROPUBIC PROSTATECTOMY; RAT; TESTIS FUNCTION; TESTIS WEIGHT;

EID: 65149088894     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2008.01208.x     Document Type: Article

References (45)

1. Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE. Life after breast cancer: Understanding women's health-related quality of life and sexual functioning. J Clin Oncol 1998;16:501-14.
2. Syrjala KL, Roth-Roemer SL, Abrams JR, Scanlan JM, Chapko MK, Visser S, Sanders JE. Prevalence and predictors of sexual dysfunction in long-term survivors of marrow transplantation. J Clin Oncol 1998;16:3148-57.
3. Arap W. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008;359:200-1.
4. Pignata S, Ballatori E, Favalli G, Scambia G. Quality of life: Gynaecological cancers. Ann Oncol 2001;12(Suppl 3):S37-42.
5. Smith DS, Carvalhal GF, Schneider K, Krygiel J, Yan Y, Catalona WJ. Quality-of-life outcomes for men with prostate carcinoma detected by screening. Cancer 2000;88:1454-63.
6. Stanford JL, Feng Z, Hamilton AS, Gilliland FD, Stephenson RA, Eley JW, Albertsen PC, Harlan LC, Potosky AL. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes Study. JAMA 2000;283:354-60.
7. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, Brook RH. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 1995;273:129-35.
8. Levine LA. Erectile dysfunction following treatment of prostate cancer: New insights and therapeutic options. J Mens Health Gen 2004;1:328-33.
9. Burnett AL, Thompson I, Thrasher B. Erectile function outcome reporting after clinically localized prostate cancer treatment. J Sex Med 2007;4(suppl 1):98.
10. Montorsi F, McCullough A. Efficacy of sildenafil citrate in men with erectile dysfunction following radical prostatectomy: A systematic review of clinical data. J Sex Med 2005;2:658-67.
11. Montorsi F, Nathan HP, McCullough A, Brock GB, Broderick G, Ahuja S, Whitaker S, Hoover A, Novack D, Murphy A, Varanese L. Tadalafil in the treatment of erectile dysfunction following bilateral nervesparing radical retropubic prostatectomy: A randomized, double-blind, placebo controlled trial. J Urol 2004;172:1036-41.
12. Montorsi F, Salonia A, Briganti A, Barbieri L, Zanni G, Suardi N, Cestari A, Montorsi P, Rigatti P. Vardenafil for the treatment of erectile dysfunction: A critical review of the literature based on personal clinical experience. Eur Urol 2005;47:612-21.
13. Montorsi F, Guazzoni G, Strambi LF, Da Pozzo LF, Nava L, Barbieri L, Rigatti P, Pizzini G, Miani A. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: Results of a prospective, randomized trial. J Urol 1997;158:1408-10.
14. Mulhall JP, Morgentaler A. Penile rehabilitation should become the norm for radical prostatectomy patients. J Sex Med 2007;4:538-43.
15. Vignozzi L, Filippi S, Morelli A, Ambrosini S, Luconi M, Vannelli GB, Donati S, Crescioli C, Zhang XH, Mirone V, Forti G, Maggi M. Effect of chronic tadalafil administration on penile hypoxia induced by cavernous neurotomy in the rat. J Sex Med 2006;3:419-31.
16. Traish AM, Guay AT. Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence. J Sex Med 2006;3:382-404.
17. Morelli A, Corona G, Filippi S, Ambrosini S, Forti G, Vignozzi L, Maggi M. Which patients with sexual dysfunction are suitable for testosterone replacement therapy? J Endocrinol Invest 2007;30:880-8.
18. Wang R. Penile rehabilitation after radical prostatectomy: Where do we stand and where are we going? J Sex Med 2007;4:1085-97.
19. Zhang XH, Morelli A, Luconi M, Vignozzi L, Filippi S, Marini M, Vannelli GB, Mancina R, Forti G, Maggi M. Testosterone regulates PDE5 expression and in vivo responsiveness to tadalafil in rat corpus cavernosum. Eur Urol 2005;47:409-16.
20. Zhang XH, Filippi S, Morelli A, Vignozzi L, Luconi M, Donati S, Forti G, Maggi M. Testosterone restores diabetes-induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes. J Sex Med 2006;3:253-64.
21. Morelli A, Filippi S, Mancina R, Luconi M, Vignozzi L, Marini M, Orlando C, Vannelli GB, Aversa A, Natali A, Forti G, Giorgi M, Jannini EA, Ledda F, Maggi M. Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa. Endocrinology 2004;145:2253-63.
22. Harris AL. Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2002;2:38-47.
23. Durand RE, Raleigh JA. Identification of nonproliferating but viable hypoxic tumor cells in vivo. Cancer Res 1998;58:3547-50.
24. Bennewith KL, Raleigh JA, Durand RE. Orally administered pimonidazole to label hypoxic tumor cells. Cancer Res 2002;62:6827-30.
25. Vignozzi L, Morelli A, Filippi S, Vannelli GB, Mungai S, Marini M, Boddi V, Forti G, Maggi M. Effect of sildenafil administration on penile hypoxia induced by cavernous neurotomy in the rat. Int J Impot Res 2008;20:60-7.
26. Vignozzi L, Filippi S, Luconi M, Morelli A, Mancina R, Marini M, Vannelli GB, Granchi S, Orlando C, Gelmini S, Ledda F, Forti G, Maggi M. Oxytocin receptor is expressed in the penis and mediates an estrogen-dependent smooth muscle contractility. Endocrinology 2004;145:1823-34.
27. De Lean A, Munson PJ, Rodbard D. Simultaneous analysis of families of sigmoidal curves: Applications to biossay, radioligand assay, and physiological dose-response curves. Am J Physiol 1978;235:E97-102.
28. Mancina R, Filippi S, Marini M, Morelli A, Vignozzi L, Salonia A, Montorsi F, Mondaini N, Vannelli GB, Donati S, Lotti F, Forti G, Maggi M. Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens. Mol Hum Reprod 2005;11:107-15.
29. McCullough AR, Levine LA, Padma-Nathan H. Return of nocturnal erections and erectile function after bilateral nerve-sparing radical prostatectomy in men treated nightly with sildenafil citrate: Subanalysis of a longitudinal randomized double-blind placebo-controlled trial. J Sex Med 2008;5:476-84.
30. Moreland RB. Is there a role of hypoxemia in penile fibrosis: A viewpoint presented to the Society for the Study of Impotence. Int J Impot Res 1998;10:113-20.
31. Kim N, Vardi Y, Padma-Nathan H, Daley J, Goldstein I, Saenz de Tejada I. Oxygen tension regulates the nitric oxide pathway. Physiological role in penile erection. J Clin Invest 1993;91:437-42.
32. Mulhall JP, Müller A, Donohue JF, Mullerad M, Kobylarz K, Paduch DA, Tal R, Li PS, Cohen-Gould L, Scardino PT. The functional and structural consequences of cavernous nerve injury are ameliorated by sildenafil citrate. J Sex Med 2008;5:1126-36.
33. Traish AM, Guay AT, Feeley R, Saad F. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction. J Androl 2009;30:10-22.
34. Morelli A, Filippi S, Zhang XH, Luconi M, Vignozzi L, Mancina R, Maggi M. Peripheral regulatory mechanisms in erection. Int J Androl 2005;28(suppl 2):23-7.
35. Canguven O, Burnett A. Cavernous nerve injury using rodent animal models. J Sex Med 2008;5:1776-85.
36. Quinlan DM, Nelson RJ, Partin AW, Mostwin JL, Walsh PC. The rat as a model for the study of penile erection. J Urol 1989;141:656-61.
37. Carosa E, Benvenga S, Trimarchi F, Lenzi A, Pepe M, Simonelli C, Jannini EA. Sexual inactivity results in reversible reduction of LH bioavailability. Int J Impot Res 2002;14:93-9.
38. Miller LR, Partin AW, Chan DW, Bruzek D, As Dobs, Epstein J, Walsh P. Influence of radical prostatectomy on serum hormone levels. J Urol 1998;160:449-53.
39. Luboshitzky R, Ariel Aviv, Hefetz A, Herer P, Shen-orr Z, Lavie L, Lavie P. Decreased pituitary-gonadal secretion in men with obstructive sleep apnea. J Clin Endocrinol Metab 2002;87:3394-8.
40. Farias JG, Buston-Obregon E, Tapia PJ, Gutierrez E, Zepeda A, Juantok C, Cruz G, Soto G, Benites J, Reyes JG. Time course of endocrine changes in the hypophysis-gonadal axis induced by hypobaric hypoxia in male rats. J Reprod Dev 2008;54:18-21.
41. Huggins C, Hodges CV. The effects of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1941;1:293-7.
42. Kaufman JM, Graydon RJ. Androgen replacement after curative radical prostatectomy for prostate cancer in hypogonadal men. J Urol 2004;172:920-2.
43. Agarwal PK, Oefelein MG. Testosterone replacement therapy after primary treatment for prostate cancer. J Urol 2005;173:533-6.
44. Sarosdy MF. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy. Cancer 2007;109:536-41.
45. Rhoden EL, Averbeck MA, Teloken PE. Androgen replacement in men undergoing treatment for prostate cancer. J Sex Med 2008;5:2202-8.